What's Happening

You are here

[Issue No. 160] PSS E-Bulletin December 2019

Transforming end-to-end refill/repeat medication order and delivery service to patients and caregiver.

PSS has developed a guideline for controlled drug disposal. Click on links for the guideline and suggested form for recording purposes. 

The Health Sciences Authority (HSA) would like to inform healthcare professionals about the consumer-level recall of three metformin products which have been detected to contain trace amounts of N-nitrosodimethylamine (NDMA) beyond the internationally acceptable level. HSA has tested all the metformin products in the Singapore market, and found that besides these three products, none of the other 43 metformin products marketed in Singapore contain NDMA above the acceptable level.

HSA adverse drug reaction including present ‘SCAR WATCH’, a guide on drugs associated with Severe Cutaneous Adverse Reactions reported locally and a Q&A guide on the use of a new mobile-friendly adverse event reporting form for submission of AE reports through mobile devices.